Wu, S. A., Jia, D. T., Schwartz, M., Mulcahy, M., Guo, K., Tate, M. C., . . . Lukas, R. V. (2023). HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen. Taylor & Francis Group.
Chicago Style (17th ed.) CitationWu, Scott A., et al. HER2+ Esophageal Carcinoma Leptomeningeal Metastases Treated with Intrathecal Trastuzumab Regimen. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationWu, Scott A., et al. HER2+ Esophageal Carcinoma Leptomeningeal Metastases Treated with Intrathecal Trastuzumab Regimen. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.